Systemic Treatments for Advanced Small Bowel Adenocarcinoma: A Systematic Review.
Paola Di NardoSilvio Ken GarattiniElena TorrisiValentina FanottoGianmaria MioloAngela BuonadonnaFabio PuglisiPublished in: Cancers (2022)
No good level evidence is available on the use of bevacizumab, anti-epidermal growth factor receptor, targeted agents or immunotherapy. First-line treatments are largely derived from colorectal cancer protocols, mainly oxaliplatin-based doublets.